Foster City, CA, United States of America

Wayne Volkmuth

This inventor holds 8 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Atreca, Inc., Ceres, Inc.. Active years: 2014-2026.

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 75.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Foster City, CA (US) (2014 - 2022)
San Carlos, CA (US) (2023)

Company Filing History:

Years Active: 2014-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545723 - ANTI-CSP ANTIBODIES (2026-02-10),

2. 11655290 - Anti-CSP antibodies (2023-05-23),

3. 11472885 - Antibodies that bind tumor tissue for diagnosis and therapy (2022-10-18),

4. 10620219 - Use of nanoexpression to interrogate antibody repertoires (2020-04-14),

5. 10329575 - Regulatory sequence for plants (2019-06-25),

6. 9834766 - DNA barcodes for multiplexed sequencing (2017-12-05),

7. 9029523 - Promoter, promoter control elements, and combinations, and uses thereof (2015-05-12),

8. 8877916 - Promoter, promoter control elements, and combinations, and uses thereof (2014-11-04),

Title: Wayne Volkmuth: Innovator in Antibody Development

Introduction

Wayne Volkmuth, based in Foster City, California, is a notable inventor with a remarkable portfolio that includes seven patents. His work primarily focuses on the development of antibodies aimed at combating critical health issues, including malaria and cancer.

Latest Patents

Among his latest patents, Wayne has made significant strides in the field of immunology. One of his key inventions involves anti-circumsporozoite (CSP) antibodies, which offer potential solutions for the treatment and prevention of malaria. The patent provides detailed methodologies for producing these antibodies and their clinical applications. Another vital patent focuses on antibodies that bind to tumor tissue through interactions with extracellular RNA-protein complexes. This innovation is geared towards inducing immune responses and inhibiting the growth of tumor cells, showcasing Wayne's contributions to cancer therapy.

Career Highlights

Wayne Volkmuth has garnered extensive experience through his work with several prominent companies, including Atreca, Inc. and Ceres, Inc. His contributions in these organizations have significantly advanced research and development in antibody therapeutics.

Collaborations

During his career, Wayne has collaborated with talented professionals such as Nickolai Alexandrov and Nestor Apuya. These collaborations have fostered innovative ideas and driven the development of groundbreaking medical technologies.

Conclusion

Wayne Volkmuth's inventive endeavors in the field of antibody development reflect his commitment to advancing medicine and improving health outcomes. With his impressive record of patents and collaborations, he continues to play a pivotal role in shaping the future of therapeutics in combating diseases like malaria and cancer.